Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tingyu Liang, Yixuan Song, Lingui Gu, Yu Wang & Wenbin Ma. (2023) Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma. International Journal of General Medicine 16, pages 4121-4141.
Read now
Read now
Kevin Kos, Camilla Salvagno, Max D. Wellenstein, Muhammad A. Aslam, Denize A. Meijer, Cheei-Sing Hau, Kim Vrijland, Daphne Kaldenbach, Elisabeth A.M. Raeven, Martina Schmittnaegel, Carola H. Ries & Karin E. de Visser. (2022) Tumor-associated macrophages promote intratumoral conversion of conventional CD4+ T cells into regulatory T cells via PD-1 signalling. OncoImmunology 11:1.
Read now
Read now
Sayuri Herath, Sajad Razavi Bazaz, James Monkman, Majid Ebrahimi Warkiani, Derek Richard, Ken O’Byrne & Arutha Kulasinghe. (2020) Circulating tumor cell clusters: Insights into tumour dissemination and metastasis. Expert Review of Molecular Diagnostics 20:11, pages 1139-1147.
Read now
Read now
Alexandra Giatromanolaki, Alison H. Banham, Adrian L. Harris & Michael I. Koukourakis. (2019) FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma. Experimental Lung Research 45:3-4, pages 76-83.
Read now
Read now
Articles from other publishers (66)
Catarina Macedo, Paulo C. Costa & Francisca Rodrigues. (2024) Bioactive compounds from Actinidia arguta fruit as a new strategy to fight glioblastoma. Food Research International 175, pages 113770.
Crossref
Crossref
Yu-Chen Yang, Yu Zhu, Si-Jia Sun, Can-Jun Zhao, Yang Bai, Jin Wang & Li-Tian Ma. (2023) ROS regulation in gliomas: implications for treatment strategies. Frontiers in Immunology 14.
Crossref
Crossref
Peng Zhang, Yuting Wang, Qianru Miao & Ying Chen. (2023) The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components. Biomedicine & Pharmacotherapy 167, pages 115569.
Crossref
Crossref
Jing Luo, Ziyi Wang, Xuemei Zhang, Haihui Yu, Hui Chen, Kun Song, Yang Zhang, Lawrence M. Schwartz, Hongzhuan Chen, Yingbin Liu & Rong Shao. (2023) Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1. Cancers 15:17, pages 4257.
Crossref
Crossref
Guomu Liu, Zenan Zhang, Yixuan Wu, Jingyue Feng, Yue Lan, Dai Dong, Yu Liu, Hongyan Yuan, Guixiang Tai, Shanshan Li & Weihua Ni. (2023) Anti-PD-L1 antibody reverses the immune tolerance induced by multiple MUC1-MBP vaccine immunizations by increasing the CD80/PD-L1 ratio, resulting in DC maturation, and decreasing Treg activity in B16-MUC1 melanoma-bearing mice. International Immunopharmacology 121, pages 110487.
Crossref
Crossref
Yi Pu, Guanyu Zhou, Kejia Zhao, Yaohui Chen & Shensi Shen. (2023) Immunotherapy for Recurrent Glioma—From Bench to Bedside. Cancers 15:13, pages 3421.
Crossref
Crossref
Rahmad Aji Prasetya & Devyani Diah Wulansari. 2023. Regulatory T Cells - New Insights. Regulatory T Cells - New Insights.
Anita L. Kalluri, Pavan P. Shah & Michael Lim. (2023) The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches. International Journal of Molecular Sciences 24:3, pages 2020.
Crossref
Crossref
Peipei Wang, Zhishuo Mo, Ying Zhang, Chunxia Guo, Trevor Kudzai Chikede, Dabiao Chen, Ziying Lei, Zhiliang Gao, Qian Zhang & Qiaoxia Tong. (2023) Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon. Frontiers in Immunology 13.
Crossref
Crossref
Alessia Filippone, Deborah Mannino, Giovanna Casili, Marika Lanza, Irene Paterniti, Salvatore Cuzzocrea, Anna Paola Capra, Lorenzo Colarossi, Dario Giuffrida, Sofia Paola Lombardo & Emanuela Esposito. (2022) Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management. International Journal of Molecular Sciences 23:24, pages 15693.
Crossref
Crossref
Fengge Zhou, Gulidanna Shayan, Shiran Sun, Xiaodong Huang, Xuesong Chen, Kai Wang, Yuan Qu, Runye Wu, Ye Zhang, Qingfeng Liu, Jianghu Zhang, Jingwei Luo, Xinqi Shi, Yang Liu, Bin Liang, Ye-Xiong Li, Jingbo Wang & Junlin Yi. (2022) Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer. Frontiers in Immunology 13.
Crossref
Crossref
Makoto Ohno, Shigehisa Kitano, Kaishi Satomi, Akihiko Yoshida, Yasuji Miyakita, Masamichi Takahashi, Shunsuke Yanagisawa, Yukie Tamura, Koichi Ichimura & Yoshitaka Narita. (2022) Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas. Journal of Neuro-Oncology 160:2, pages 463-472.
Crossref
Crossref
Karl John Habashy, Rana Mansour, Charbel Moussalem, Raymond Sawaya & Michel J. Massaad. (2022) Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them. British Journal of Cancer 127:6, pages 976-987.
Crossref
Crossref
Lizhi Pang, Fatima Khan, Amy B. Heimberger & Peiwen Chen. (2022) Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma. Trends in Cancer 8:10, pages 839-854.
Crossref
Crossref
Mitrajit Ghosh, Anna M. Lenkiewicz & Bozena Kaminska. (2022) The Interplay of Tumor Vessels and Immune Cells Affects Immunotherapy of Glioblastoma. Biomedicines 10:9, pages 2292.
Crossref
Crossref
Guanjie Jia, Hao Yang, Kaiqun Wang, Di Huang, Weiyi Chen & Yanhu Shan. (2022) The modeling study of the effect of morphological behaviors of extracellular matrix fibers on the dynamic interaction between tumor cells and antitumor immune response. International Journal for Numerical Methods in Biomedical Engineering 38:9.
Crossref
Crossref
Tanvi H. Visal, Petra den Hollander, Massimo Cristofanilli & Sendurai A. Mani. (2022) Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?. British Journal of Cancer 127:2, pages 173-184.
Crossref
Crossref
Dan Liu, Yue Wan, Ning Qu, Qiang Fu, Chao Liang, Lingda Zeng & Yang Yang. (2022) LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma. Frontiers in Public Health 10.
Crossref
Crossref
Haniyeh Ghaffari-Nazari, Masoumeh Alimohammadi, Reza Alimohammadi, Elham Rostami, Mohsen Bakhshandeh, Thomas J. Webster, Ghanbar Mahmoodi Chalbatani, Jalil Tavakkol-Afshari & Seyed Amir Jalali. (2022) Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model. International Immunopharmacology 108, pages 108737.
Crossref
Crossref
Oliver Y. Tang, Lifeng Tian, Todd Yoder, Rong Xu, Irina Kulikovskaya, Minnal Gupta, Jan Joseph Melenhorst, Simon F. Lacey, Donald M. O’Rourke & Zev A. Binder. (2022) PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response. Frontiers in Immunology 13.
Crossref
Crossref
Sonja Faßbender, Kevin Sondenheimer, Marc Majora, Jennifer Schindler, Friederike V. Opitz, Marius Pollet, Thomas Haarmann-Stemmann, Jean Krutmann & Heike Weighardt. (2022) Keratinocytes Counteract UVB-Induced Immunosuppression in Mice through HIF-1a Signaling. Journal of Investigative Dermatology 142:4, pages 1183-1193.
Crossref
Crossref
Lujun Shen, Ying Wu, Han Qi, Yiquan Jiang, Jietian Jin, Fei Cao, Shuanggang Chen, Yuanzhong Yang, Tao Huang, Ze Song, Qifeng Chen, Yinqi Zhang, Jinqing Mo, Dandan Li, Xiaoshi Zhang & Weijun Fan. (2022) Inducible Regulatory T Cell Predicts Efficacy of PD‐1 Blockade Therapy in Melanoma. Advanced Therapeutics 5:4.
Crossref
Crossref
Elena Codrici, Ionela-Daniela Popescu, Cristiana Tanase & Ana-Maria Enciu. (2022) Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment. International Journal of Molecular Sciences 23:5, pages 2509.
Crossref
Crossref
Hajar Alemohammad, Basira Najafzadeh, Zahra Asadzadeh, Amir Baghbanzadeh, Farid Ghorbaninezhad, Arezoo Najafzadeh, Hossein Safarpour, Renato Bernardini, Oronzo Brunetti, Margherita Sonnessa, Rossella Fasano, Nicola Silvestris & Behzad Baradaran. (2022) The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer. Biomedicine & Pharmacotherapy 146, pages 112516.
Crossref
Crossref
Qilin Huang, Dongmei Wang, Guojie Yao & Hongxiang Wang. (2022) Impact of General Factors on Glioma Immunotherapy. Journal of Clinical Neurology 18:1, pages 3.
Crossref
Crossref
Fen Liu, Saisai Zhang, Danny Ka-Ho Wong, Fung Yu Huang, Ka-Shing Cheung, Lung Yi Mak, James Fung, Man-Fung Yuen & Wai-Kay Seto. (2022) Phenotypic Changes of PD-1 and GITR in T Cells Are Associated With Hepatitis B Surface Antigen Seroclearance. Journal of Clinical Gastroenterology 56:1, pages e31-e37.
Crossref
Crossref
Takashi MaruYama, Shuhei Kobayashi, Hiroyuki Shibata, WanJun Chen & Yuji Owada. (2021) Curcumin analog GO‐Y030 boosts the efficacy of anti‐PD‐1 cancer immunotherapy. Cancer Science 112:12, pages 4844-4852.
Crossref
Crossref
Ying Zhang, Wenping Ma, Wenhua Fan, Changyuan Ren, Jianbao Xu, Fan Zeng, Zhaoshi Bao, Tao Jiang & Zheng Zhao. (2021) Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma. Cell Death & Disease 12:12.
Crossref
Crossref
Angeliki Datsi & Rüdiger V. Sorg. (2021) Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End. Frontiers in Immunology 12.
Crossref
Crossref
Benjamin T. Himes, Philipp A. Geiger, Katayoun Ayasoufi, Adip G. Bhargav, Desmond A. Brown & Ian F. Parney. (2021) Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications. Frontiers in Oncology 11.
Crossref
Crossref
Fernanda Bueno Morrone, Pedro Vargas, Liliana Rockenbach & Thamiris Becker Scheffel. (2021) P2Y12 Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment. Molecules 26:20, pages 6146.
Crossref
Crossref
Alice Valentin-Torres, Cora Day, Jennifer M. Taggart, Nicholas Williams, Samantha R. Stubblefield, Valerie D. Roobrouck, Jelle Beyens & Anthony E. Ting. (2021) Multipotent adult progenitor cells induce regulatory T cells and promote their suppressive phenotype via TGFβ and monocyte-dependent mechanisms. Scientific Reports 11:1.
Crossref
Crossref
Runze Qiu, Yue Zhong, Qingquan Li, Yingbin Li & Hongwei Fan. (2021) Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Minlin Jiang, Chunyan Wu, Liping Zhang, Chenglong Sun, Hao Wang, Yi Xu, Hui Sun, Jun Zhu, Wencheng Zhao, Qiyu Fang, Jia Yu, Peixin Chen, Shengyu Wu, Zixuan Zheng, Yayi He & Caicun Zhou. (2021) FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III. Journal for ImmunoTherapy of Cancer 9:5, pages e002339.
Crossref
Crossref
Jiayi Zhou, Xiaojuan Pei, Yingui Yang, Zhu Wang, Weijie Gao, Ran Ye, Xiantong Zhang, Jiangang Liu, Zhuohao Liu, Xinzhi Yang, Jingli Tao, Chunshan Gu, Wei Hu, Franky Lueng Chan, Xin Li, Jie Mao & Dinglan Wu. (2021) Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma. Journal for ImmunoTherapy of Cancer 9:4, pages e001937.
Crossref
Crossref
Sheng Wang & Xia Xu. (2021) An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma. Frontiers in Oncology 11.
Crossref
Crossref
Giuseppe Nicolò Fanelli, Dario Grassini, Valerio Ortenzi, Francesco Pasqualetti, Nicola Montemurro, Paolo Perrini, Antonio Giuseppe Naccarato & Cristian Scatena. (2021) Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies. Genes 12:3, pages 445.
Crossref
Crossref
Kuan Hu, Juanni Li, Geting Wu, Lei Zhou, Xiang Wang, Yuanliang Yan & Zhijie Xu. (2021) The novel roles of virus infection-associated gene CDKN1A in chemoresistance and immune infiltration of glioblastoma. Aging 13:5, pages 6662-6680.
Crossref
Crossref
Kevin KosKarin E. de Visser. (2021) The Multifaceted Role of Regulatory T Cells in Breast Cancer. Annual Review of Cancer Biology 5:1, pages 291-310.
Crossref
Crossref
Hongsheng Wang, Huangao Zhou, Jianing Xu, Yunpeng Lu, Xiaoyun Ji, Yizheng Yao, Hou Chao, Jun Zhang, Xiaochun Zhang, Shun Yao, Yinqiu Wu & Jie Wan. (2021) Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy. Cancer Letters 496, pages 134-143.
Crossref
Crossref
Chunxiao Li, Ping Jiang, Shuhua Wei, Xiaofei Xu & Junjie Wang. (2020) Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Molecular Cancer 19:1.
Crossref
Crossref
Yueping Liu, Lei Zhao, Liyan Xue & Yingyong Hou. (2020) Selected updates in molecular and genomic pathology of esophageal cancer. Annals of the New York Academy of Sciences 1482:1, pages 225-235.
Crossref
Crossref
Silvia M. Bacot, Taylor A. Harper, Rebecca L. Matthews, Christie Jane Fennell, Adovi Akue, Mark A. KuKuruga, Shiowjen Lee, Tao Wang & Gerald M. Feldman. (2020) Exploring the Potential Use of a PBMC-Based Functional Assay to Identify Predictive Biomarkers for Anti-PD-1 Immunotherapy. International Journal of Molecular Sciences 21:23, pages 9023.
Crossref
Crossref
Yibin Miao, Liuting He, Xiaoyu Qi & Xiaoping Lin. (2020) Injecting Immunosuppressive M2 Macrophages Alleviates the Symptoms of Periodontitis in Mice. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Ivana Manini, Federica Caponnetto, Emiliano Dalla, Tamara Ius, Giuseppe Maria Della Pepa, Enrico Pegolo, Anna Bartolini, Giuseppe La Rocca, Grazia Menna, Carla Di Loreto, Alessandro Olivi, Miran Skrap, Giovanni Sabatino & Daniela Cesselli. (2020) Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways. Cancers 12:10, pages 2960.
Crossref
Crossref
M He, X Chen, M Luo, L Ouyang, L Xie, Z Huang & A Liu. (2020) Suppressor of cytokine signaling 1 inhibits the maturation of dendritic cells involving the nuclear factor kappa B signaling pathway in the glioma microenvironment. Clinical and Experimental Immunology 202:1, pages 47-59.
Crossref
Crossref
A. Charlotte M. T. de Wolf, Carla A. Herberts & Marcel H. N. Hoefnagel. (2020) Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised. Frontiers in Medicine 7.
Crossref
Crossref
Ana Rita Pombo Antunes, Isabelle Scheyltjens, Johnny Duerinck, Bart Neyns, Kiavash Movahedi & Jo A Van Ginderachter. (2020) Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies. eLife 9.
Crossref
Crossref
William James Kelly, Amber Jin Giles & Mark Gilbert. (2020) T lymphocyte-targeted immune checkpoint modulation in glioma. Journal for ImmunoTherapy of Cancer 8:1, pages e000379.
Crossref
Crossref
莹莹 张. (2020) Research Progress of Related Mechanisms about Treatment of Glioma by Medicine. Pharmacy Information 09:02, pages 78-84.
Crossref
Crossref
Darya S Nesterova, Vishal Midya, Brad E Zacharia, Elizabeth A Proctor, Sang Y Lee, Lindsay C Stetson, Justin D Lathia, Joshua B Rubin, Kristin A Waite, Michael E Berens, Jill S Barnholtz-Sloan & James R Connor. (2020) Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastoma. Neuro-Oncology Advances 2:1.
Crossref
Crossref
Chiara V. Locarno, Matteo Simonelli, Claudia Carenza, Arianna Capucetti, Elisabetta Stanzani, Elena Lorenzi, Pasquale Persico, Silvia Della Bella, Lorena Passoni, Domenico Mavilio, Raffaella Bonecchi, Massimo Locati & Benedetta Savino. (2020) Role of myeloid cells in the immunosuppressive microenvironment in gliomas. Immunobiology 225:1, pages 151853.
Crossref
Crossref
Kim Margolin, Michael Davies, Harriet Kluger & Hussein Tawbi. 2020. Cutaneous Melanoma. Cutaneous Melanoma
1421
1454
.
Julian Burks, Alia Fleury, Sarah Livingston & Jill P. Smith. (2019) ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression. Cancer Immunology, Immunotherapy 68:12, pages 2029-2039.
Crossref
Crossref
Gang Xu, Lejia Sun, Yunzhu Li, Feihu Xie, Xiaoxiang Zhou, Huayu Yang, Shunda Du, Haifeng Xu & Yilei Mao. (2019) The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis. Frontiers in Oncology 9.
Crossref
Crossref
Radhika R. Gudi, Subha Karumuthil-Melethil, Nicolas Perez, Gongbo Li & Chenthamarakshan Vasu. (2019) Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance. Scientific Reports 9:1.
Crossref
Crossref
Lahari Saikia, Trinayan Deka, Pranjal Deori, Rasmi Roy, Md Ezaz Hussain & Reema Nath. (2019) Frequencies of Regulatory Subsets of CD4+ TH Cells in Peripheral Blood in Mycobacterium Tuberculosis-Infected Individuals and Healthy Contacts in a High-Burden Setting from Assam, Northeast India. Indian Journal of Medical Microbiology 37:3, pages 370-375.
Crossref
Crossref
Maria E. Mycielska, Markus T. J. Mohr, Katharina Schmidt, Konstantin Drexler, Petra Rümmele, Sebastian Haferkamp, Hans J. Schlitt, Andreas Gaumann, Jerzy Adamski & Edward K. Geissler. (2019) Potential Use of Gluconate in Cancer Therapy. Frontiers in Oncology 9.
Crossref
Crossref
Kerstetter-Fogle, Shukla, Wang, Beiss, Harris, Sloan & Steinmetz. (2019) Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy. Cancers 11:4, pages 515.
Crossref
Crossref
Ruo Qiao Chen, Feng Liu, Xin Yao Qiu & Xiao Qian Chen. (2019) The Prognostic and Therapeutic Value of PD-L1 in Glioma. Frontiers in Pharmacology 9.
Crossref
Crossref
Aras Toker & Pamela S. Ohashi. 2019.
193
261
.
Kim Margolin, Michael Davies, Harriet Kluger & Hussein Tawbi. 2019. Cutaneous Melanoma. Cutaneous Melanoma
1
34
.
John Lynes, Victoria Sanchez, Gifty Dominah, Anthony Nwankwo & Edjah Nduom. (2018) Current Options and Future Directions in Immune Therapy for Glioblastoma. Frontiers in Oncology 8.
Crossref
Crossref
Christopher Chin, Emma S. Lunking, Macarena de la Fuente & Nagi G. Ayad. (2018) Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme. Frontiers in Oncology 8.
Crossref
Crossref
Wen-Chao Wang, Xiao-Feng Zhang, Jian Peng, Xi-Feng Li, Ai-Li Wang, Ya-Qin Bie, Le-Hua Shi, Mou-Bin Lin & Xiao-Feng Zhang. (2018) Survival Mechanisms and Influence Factors of Circulating Tumor Cells. BioMed Research International 2018, pages 1-9.
Crossref
Crossref
Diana Matias, Joana Balça-Silva, Grazielle C. da Graça, Caroline M. Wanjiru, Lucy W. Macharia, Carla Pires Nascimento, Natalia R. Roque, Juliana M. Coelho-Aguiar, Cláudia M. Pereira, Marcos F. Dos Santos, Luciana S. Pessoa, Flavia R. S. Lima, Alberto Schanaider, Valéria P. Ferrer & Vivaldo Moura-Neto. (2018) Microglia/Astrocytes–Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref